{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T15:06:34Z","timestamp":1787843194350,"version":"build-2784847793"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,1,12]],"date-time":"2026-01-12T00:00:00Z","timestamp":1768176000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,2,9]],"date-time":"2026-02-09T00:00:00Z","timestamp":1770595200000},"content-version":"vor","delay-in-days":28,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Transl Med"],"DOI":"10.1186\/s12967-025-07552-6","type":"journal-article","created":{"date-parts":[[2026,1,12]],"date-time":"2026-01-12T06:33:35Z","timestamp":1768199615000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Serum cystatin C as a biomarker for diabetic retinopathy and its role in diabetic retinopathy-diabetic kidney disease comorbidity"],"prefix":"10.1186","volume":"24","author":[{"given":"Xiaosi","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weichen","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yiyun","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hanyu","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linghui","family":"Pi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinming","family":"Gu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3372-0798","authenticated-orcid":false,"given":"Xinyuan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,1,12]]},"reference":[{"key":"7552_CR1","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1016\/j.kint.2020.01.039","volume":"98","author":"TE Farrah","year":"2020","unstructured":"Farrah TE, Dhillon B, Keane PA, Webb DJ, Dhaun N. The eye, the kidney, and cardiovascular disease: old concepts, better tools, and new horizons. Kidney Int. 2020;98:323\u201342. https:\/\/doi.org\/10.1016\/j.kint.2020.01.039.","journal-title":"Kidney Int"},{"key":"7552_CR2","doi-asserted-by":"publisher","first-page":"1040319","DOI":"10.3389\/fpubh.2022.1040319","volume":"10","author":"X Chen","year":"2023","unstructured":"Chen X, Zhang X, Gong Z, Yang Y, Zhang X, Wang Q, Wang Y, Xie R. The link between diabetic retinal and renal microvasculopathy is associated with dyslipidemia and upregulated circulating level of cytokines. Front Public Health. 2023;10:1040319. https:\/\/doi.org\/10.3389\/fpubh.2022.1040319.","journal-title":"Front Public Health"},{"key":"7552_CR3","doi-asserted-by":"publisher","first-page":"e1","DOI":"10.1111\/aos.14487","volume":"99","author":"YT Hsieh","year":"2021","unstructured":"Hsieh YT, Hsieh MC. Time-sequential correlations between diabetic kidney disease and diabetic retinopathy in type 2 diabetes - an 8-year prospective cohort study. Acta Ophthalmol. 2021;99:e1\u20136. https:\/\/doi.org\/10.1111\/aos.14487.","journal-title":"Acta Ophthalmol"},{"key":"7552_CR4","doi-asserted-by":"publisher","first-page":"1221","DOI":"10.7754\/clin.lab.2013.120804","volume":"59","author":"Y Jeon","year":"2013","unstructured":"Jeon Y, Kim MH, Lee W-I, Kang SY. Cystatin C as an early marker of diabetic nephropathy in patients with type 2 diabetes. Clin Lab. 2013;59:1221\u201329. https:\/\/doi.org\/10.7754\/clin.lab.2013.120804.","journal-title":"Clin Lab"},{"key":"7552_CR5","doi-asserted-by":"publisher","first-page":"1195","DOI":"10.1093\/ndt\/gft509","volume":"29","author":"L Fan","year":"2014","unstructured":"Fan L, Inker LA, Rossert J, Froissart M, Rossing P, Mauer M, Levey AS. Glomerular filtration rate estimation using cystatin C alone or combined with creatinine as a confirmatory test. Nephrol Dial Transpl. 2014;29:1195\u2013203. https:\/\/doi.org\/10.1093\/ndt\/gft509.","journal-title":"Nephrol Dial Transpl"},{"key":"7552_CR6","doi-asserted-by":"publisher","first-page":"1737","DOI":"10.1056\/NEJMoa2102953","volume":"385","author":"LA Inker","year":"2021","unstructured":"Inker LA, Eneanya ND, Coresh J, Tighiouart H, Wang D, Sang Y, Crews DC, Doria A, Estrella MM, Froissart M, et al. New creatinine- and Cystatin C-Based equations to estimate GFR without Race. N Engl J Med. 2021;385:1737\u201349. https:\/\/doi.org\/10.1056\/NEJMoa2102953.","journal-title":"N Engl J Med"},{"key":"7552_CR7","doi-asserted-by":"publisher","unstructured":"KDIGO. Clinical Practice guideline for diabetes Management in chronic kidney disease. Kidney Int. 2022 2022;102:S1\u2013127. https:\/\/doi.org\/10.1016\/j.kint.2022.06.008.","DOI":"10.1016\/j.kint.2022.06.008"},{"key":"7552_CR8","doi-asserted-by":"publisher","first-page":"S191","DOI":"10.2337\/dc23-S011","volume":"46","author":"NA ElSayed","year":"2022","unstructured":"ElSayed NA, Aleppo G, Aroda VR, Bannuru RR, Brown FM, Bruemmer D, Collins BS, Hilliard ME, Isaacs D, Johnson EL, et al. 11. Chronic kidney disease and risk Management: standards of Care in diabetes-2023. Diabetes Care. 2022;46:S191\u2013202. https:\/\/doi.org\/10.2337\/dc23-S011.","journal-title":"Diabetes Care"},{"key":"7552_CR9","doi-asserted-by":"publisher","first-page":"873","DOI":"10.2337\/dc23-2364","volume":"47","author":"D He","year":"2024","unstructured":"He D, Gao B, Wang J, Yang C, Zhao MH, Zhang L. The difference between cystatin C- and creatinine-based estimated glomerular filtration rate and risk of diabetic microvascular complications among adults with diabetes: a population-based cohort study. Diabetes Care. 2024;47:873\u201380. https:\/\/doi.org\/10.2337\/dc23-2364.","journal-title":"Diabetes Care"},{"key":"7552_CR10","doi-asserted-by":"publisher","first-page":"sfaf003","DOI":"10.1093\/ckj\/sfaf003","volume":"18","author":"Q Liu","year":"2025","unstructured":"Liu Q, Welsh P, Celis-Morales C, Ho FK, Lees JS, Mark PB. Discordance between cystatin C-based and creatinine-based estimated glomerular filtration rate and health outcomes in adults: a systematic review and meta-analysis. Clin Kidney J. 2025;18:sfaf003. https:\/\/doi.org\/10.1093\/ckj\/sfaf003.","journal-title":"Clin Kidney J"},{"key":"7552_CR11","doi-asserted-by":"publisher","first-page":"3139","DOI":"10.1002\/ehf2.13975","volume":"9","author":"A Pinsino","year":"2022","unstructured":"Pinsino A, Fabbri M, Braghieri L, Bohn B, Gaudig AJ, Kim A, Takeda K, Naka Y, Sayer GT, Uriel N, et al. The difference between cystatin C- and creatinine-based assessment of kidney function in acute heart failure. ESC Heart Fail. 2022;9:3139\u201348. https:\/\/doi.org\/10.1002\/ehf2.13975.","journal-title":"ESC Heart Fail"},{"key":"7552_CR12","doi-asserted-by":"publisher","unstructured":"Farrington DK, Surapaneni A, Matsushita K, Seegmiller JC, Coresh J, Grams ME. Discrepancies between Cystatin C-Based and creatinine-based eGFR. Clin J Am Soc Nephrol. 2023;18:1143\u201352. https:\/\/doi.org\/10.2215\/cjn.0000000000000217.","DOI":"10.2215\/cjn.0000000000000217"},{"key":"7552_CR13","doi-asserted-by":"publisher","first-page":"e0149448","DOI":"10.1371\/journal.pone.0149448","volume":"11","author":"A Rodriguez Poncelas","year":"2016","unstructured":"Rodriguez Poncelas A, Mundet Tuduri X, Miravet Jim\u00e9nez, Casellas A, Barrot De la Puente JF, Franch Nadal J, Coll de Tuero G. Chronic kidney disease and diabetic retinopathy in patients with type 2 diabetes. PLoS One. 2016;11:e0149448. https:\/\/doi.org\/10.1371\/journal.pone.0149448.","journal-title":"PLoS One"},{"key":"7552_CR14","doi-asserted-by":"publisher","first-page":"1375","DOI":"10.1007\/s11255-014-0675-4","volume":"46","author":"H Zhang","year":"2014","unstructured":"Zhang H, Wang J, G-S Y, Shen L, Zhang Z. Diabetic retinopathy and renal function in Chinese type 2 diabetic patients. Int Urol Nephrol. 2014;46:1375\u201381. https:\/\/doi.org\/10.1007\/s11255-014-0675-4.","journal-title":"Int Urol Nephrol"},{"key":"7552_CR15","doi-asserted-by":"publisher","first-page":"1413","DOI":"10.1177\/2047487316637182","volume":"23","author":"WY Ng","year":"2016","unstructured":"Ng WY, Teo BW, Tai ES, Sethi S, Lamoureux E, Tien Yin W, Sabanayagam C. Cystatin C, chronic kidney disease and retinopathy in adults without diabetes. Eur J Prev Cardiol. 2016;23:1413\u201320. https:\/\/doi.org\/10.1177\/2047487316637182.","journal-title":"Eur J Prev Cardiol"},{"key":"7552_CR16","doi-asserted-by":"publisher","first-page":"k601","DOI":"10.1136\/bmj.k601","volume":"362","author":"NM Davies","year":"2018","unstructured":"Davies NM, Holmes MV, Davey Smith G. Reading Mendelian randomisation studies: a guide, glossary, and checklist for clinicians. BMJ. 2018;362:k601. https:\/\/doi.org\/10.1136\/bmj.k601.","journal-title":"BMJ"},{"key":"7552_CR17","doi-asserted-by":"publisher","first-page":"10","DOI":"10.2337\/cd22-as01","volume":"40","author":"Association AD: Standards of Medical Care in diabetes-2022","year":"2022","unstructured":"Association AD: Standards of Medical Care in diabetes-2022 Abridged for primary Care providers. Clin Diabetes. 2022;40:10\u201338. https:\/\/doi.org\/10.2337\/cd22-as01.","journal-title":"Clin Diabetes"},{"key":"7552_CR18","doi-asserted-by":"publisher","first-page":"P66","DOI":"10.1016\/j.ophtha.2019.09.025","volume":"127","author":"CJ Flaxel","year":"2020","unstructured":"Flaxel CJ, Adelman RA, Bailey ST, Fawzi A, Lim JI, Vemulakonda GA, Ying GS. Diabetic retinopathy preferred Practice Pattern\u00ae. Ophthalmology. 2020;127:P66\u2013145. https:\/\/doi.org\/10.1016\/j.ophtha.2019.09.025.","journal-title":"Ophthalmology"},{"key":"7552_CR19","doi-asserted-by":"publisher","first-page":"S239","DOI":"10.2337\/dc25-S011","volume":"48","author":"Committee ADAPP: 11","year":"2024","unstructured":"Committee ADAPP: 11. Chronic kidney disease and risk Management: standards of Care in diabetes-2025. Diabetes Care. 2024;48:S239\u201351. https:\/\/doi.org\/10.2337\/dc25-S011.","journal-title":"Diabetes Care"},{"key":"7552_CR20","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1053\/j.ajkd.2021.08.003","volume":"79","author":"C Delgado","year":"2022","unstructured":"Delgado C, Baweja M, Crews DC, Eneanya ND, Gadegbeku CA, Inker LA, Mendu ML, Miller WG, Moxey-Mims MM, Roberts GV, et al. A unifying approach for GFR estimation: recommendations of the NKF-ASN task force on reassessing the Inclusion of Race in diagnosing kidney disease. Am J Kidney Dis. 2022;79:268\u201388. https:\/\/doi.org\/10.1053\/j.ajkd.2021.08.003.","journal-title":"Am J Kidney Dis"},{"key":"7552_CR21","doi-asserted-by":"publisher","first-page":"4350","DOI":"10.1038\/s41467-021-24491-0","volume":"12","author":"KJ Stanzick","year":"2021","unstructured":"Stanzick KJ, Li Y, Schlosser P, Gorski M, Wuttke M, Thomas LF, Rasheed H, Rowan BX, Graham SE, Vanderweff BR, et al. Discovery and prioritization of variants and genes for kidney function in >1.2 million individuals. Nat Commun. 2021;12:4350. https:\/\/doi.org\/10.1038\/s41467-021-24491-0.","journal-title":"Nat Commun"},{"key":"7552_CR22","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1002\/gepi.21965","volume":"40","author":"J Bowden","year":"2016","unstructured":"Bowden J, Davey Smith G, Haycock PC, Burgess S. Consistent estimation in Mendelian randomization with some invalid instruments using a weighted median estimator. Genet Epidemiol. 2016;40:304\u201314. https:\/\/doi.org\/10.1002\/gepi.21965.","journal-title":"Genet Epidemiol"},{"key":"7552_CR23","doi-asserted-by":"publisher","first-page":"E19","DOI":"10.1038\/s41586-023-05837-8","volume":"615","author":"MI Kurki","year":"2023","unstructured":"Kurki MI, Karjalainen J, Palta P, Sipila TP, Kristiansson K, Donner KM, Reeve MP, Laivuori H, Aavikko M, Kaunisto MA, et al. Author correction: FinnGen provides genetic insights from a well-phenotyped isolated population. Nature. 2023;615:E19. https:\/\/doi.org\/10.1038\/s41586-023-05837-8.","journal-title":"Nature"},{"key":"7552_CR24","doi-asserted-by":"publisher","first-page":"658","DOI":"10.1002\/gepi.21758","volume":"37","author":"S Burgess","year":"2013","unstructured":"Burgess S, Butterworth A, Thompson SG. Mendelian randomization analysis with multiple genetic variants using summarized data. Genet Epidemiol. 2013;37:658\u201365. https:\/\/doi.org\/10.1002\/gepi.21758.","journal-title":"Genet Epidemiol"},{"key":"7552_CR25","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1038\/ng.3538","volume":"48","author":"Z Zhu","year":"2016","unstructured":"Zhu Z, Zhang F, Hu H, Bakshi A, Robinson MR, Powell JE, Montgomery GW, Goddard ME, Wray NR, Visscher PM, Yang J. Integration of summary data from GWAS and eQTL studies predicts complex trait gene targets. Nat Genet. 2016;48:481\u201387. https:\/\/doi.org\/10.1038\/ng.3538.","journal-title":"Nat Genet"},{"key":"7552_CR26","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1161\/CIRCHEARTFAILURE.109.856393","volume":"2","author":"MD McMurray","year":"2009","unstructured":"McMurray MD, Trivax JE, McCullough PA. Serum cystatin C, renal filtration function, and left ventricular remodeling. Circ Heart Fail. 2009;2:86\u201389. https:\/\/doi.org\/10.1161\/CIRCHEARTFAILURE.109.856393.","journal-title":"Circ Heart Fail"},{"key":"7552_CR27","doi-asserted-by":"publisher","first-page":"602","DOI":"10.4093\/dmj.2011.35.6.602","volume":"35","author":"JS Yoo","year":"2011","unstructured":"Yoo JS, Lee YM, Lee EH, Kim JW, Lee SY, Jeong K-C, Kang SA, Park JS, Nam JY, Ahn CW. Serum cystatin C reflects the progress of albuminuria. Diabetes Metab J. 2011;35:602\u201309. https:\/\/doi.org\/10.4093\/dmj.2011.35.6.602.","journal-title":"Diabetes Metab J"},{"key":"7552_CR28","doi-asserted-by":"publisher","first-page":"258","DOI":"10.3346\/jkms.2011.26.2.258","volume":"26","author":"YK Jeon","year":"2011","unstructured":"Jeon YK, Kim MR, Huh JE, Mok JY, Song SH, Kim SS, Kim BH, Lee SH, Kim YK, Kim IJ. Cystatin C as an early biomarker of nephropathy in patients with type 2 diabetes. J Korean Med Sci. 2011;26:258. https:\/\/doi.org\/10.3346\/jkms.2011.26.2.258.","journal-title":"J Korean Med Sci"},{"key":"7552_CR29","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1016\/j.dsx.2018.08.017","volume":"13","author":"MS Elsayed","year":"2019","unstructured":"Elsayed MS, El Badawy A, Ahmed A, Omar R, Mohamed A. Serum cystatin C as an indicator for early detection of diabetic nephropathy in type 2 diabetes mellitus. Diabetes Metab Syndr. 2019;13:374\u201381. https:\/\/doi.org\/10.1016\/j.dsx.2018.08.017.","journal-title":"Diabetes Metab Syndr"},{"key":"7552_CR30","doi-asserted-by":"publisher","first-page":"1807","DOI":"10.34067\/KID.0003202022","volume":"3","author":"DC Chen","year":"2022","unstructured":"Chen DC, Potok OA, Rifkin D, Estrella MM. Advantages, limitations, and clinical considerations in using cystatin C to estimate GFR. Kidney360. 2022;3:1807\u201314. https:\/\/doi.org\/10.34067\/KID.0003202022.","journal-title":"Kidney360"},{"key":"7552_CR31","doi-asserted-by":"publisher","first-page":"1430","DOI":"10.18240\/ijo.2021.09.21","volume":"14","author":"N Yang","year":"2021","unstructured":"Yang N, Lu YF, Yang X, Jiang K, Sang AM, Wu HQ. Association between cystatin C and diabetic retinopathy among type 2 diabetic patients in China: a meta-analysis. Int J Ophthalmol. 2021;14:1430\u201340. https:\/\/doi.org\/10.18240\/ijo.2021.09.21.","journal-title":"Int J Ophthalmol"},{"key":"7552_CR32","doi-asserted-by":"publisher","first-page":"1002","DOI":"10.2337\/dc13-1910","volume":"37","author":"CW Tsai","year":"2014","unstructured":"Tsai CW, Grams ME, Inker LA, Coresh J, Selvin E. Cystatin C- and creatinine-based estimated glomerular filtration rate, vascular disease, and mortality in persons with diabetes in the U.S. Diabetes Care. 2014;37:1002\u201308. https:\/\/doi.org\/10.2337\/dc13-1910.","journal-title":"Diabetes Care"},{"key":"7552_CR33","doi-asserted-by":"publisher","unstructured":"Li Y, Liu Y, Liu S, Gao M, Wang W, Chen K, et al. Diabetic vascular diseases: molecular mechanisms and therapeutic strategies. Signal Transduct Target Ther. 2023;8:152. https:\/\/doi.org\/10.1038\/s41392-023-01400-z","DOI":"10.1038\/s41392-023-01400-z"},{"key":"7552_CR34","unstructured":"Naidoo D. The link between microalbuminuria, endothelial dysfunction and cardiovascular disease in diabetes. Cardiovasc J S Afr. 2002;13:194\u20139. https:\/\/hdl.handle.net\/10520\/EJC23764"},{"key":"7552_CR35","doi-asserted-by":"publisher","unstructured":"Kim JS, Kim ES, Hwang HS, Jeong KH, Yu S-Y, Kim K. Association between albuminuria and retinal microvascular parameters measured with swept-source optical coherence tomography angiography in patients with diabetic retinopathy. PLoS One. 2024;19:e0295768. https:\/\/doi.org\/10.1371\/journal.pone.0295768","DOI":"10.1371\/journal.pone.0295768"},{"key":"7552_CR36","doi-asserted-by":"publisher","unstructured":"Eremina V, Baelde HJ, Quaggin SE. Role of the VEGF-A signaling pathway in the glomerulus: evidence for crosstalk between components of the glomerular filtration barrier. Nephron Physiol. 2007;106:32\u20137. https:\/\/doi.org\/10.1159\/000101798","DOI":"10.1159\/000101798"},{"key":"7552_CR37","doi-asserted-by":"publisher","unstructured":"Ramirez-Gonzalez J, Morales-BuenRostro L, Garcia-Covarrubias L, Pacheco-Dom\u00ednguez R, Durazo-Arvizu R, Cuevas-Medina E, et al. Assessment of the relationship between inflammation and glomerular filtration rate. Can J Kidney Health Dis. 2023;10:20543581221132748. https:\/\/doi.org\/10.1177\/20543581221132748","DOI":"10.1177\/20543581221132748"},{"key":"7552_CR38","doi-asserted-by":"publisher","unstructured":"MacIsaac RJ. Mind the gap: Discordance between cystatin C and creatinine eGFR and diabetes complications. Diabetes care. 2025;48:1158\u201360. https:\/\/doi.org\/10.2337\/dci25-0029","DOI":"10.2337\/dci25-0029"},{"key":"7552_CR39","doi-asserted-by":"publisher","unstructured":"Song Y, Yang C. Difference between estimated glomerular filtration rate based on cystatin c versus creatinine and risk of hypertension: a prospective cohort study. Eur J Med Res. 2025;30:705. https:\/\/doi.org\/10.1186\/s40001-025-02988-4","DOI":"10.1186\/s40001-025-02988-4"},{"key":"7552_CR40","doi-asserted-by":"publisher","unstructured":"Potok OA, Ix JH, Shlipak M, Bansal N, Katz R, Kritchevsky SB, et al. Using the difference in estimated glomerular filtration rate by cystatin C vs. by serum creatinine (eGFRDiff) to assess muscle mass and frailty in older adults: PO1681. J Am Soc Nephrol. 2020;31:530. https:\/\/doi.org\/10.1681\/ASN.20203110S1530b","DOI":"10.1681\/ASN.20203110S1530b"},{"key":"7552_CR41","doi-asserted-by":"publisher","unstructured":"Huang W, Liu H, Luo Y, Xiong S, Suo S, Zhang Z, et al. Inflammation and nutritional status mediated the increased of risk of atrial fibrillation recurrence associated with eGFRdiff post-ablation. J Inflamm Res. 2024:9743\u201356. https:\/\/doi.org\/10.2147\/JIR.S492947","DOI":"10.2147\/JIR.S492947"},{"key":"7552_CR42","doi-asserted-by":"publisher","unstructured":"Hsieh YT, Tsai MJ, Tu ST, Hsieh MC. Association of abnormal renal profiles and proliferative diabetic retinopathy and diabetic macular edema in an Asian population with type 2 diabetes. JAMA Ophthalmol. 2018;136:68\u201374.https:\/\/doi.org\/10.1001\/jamaophthalmol.2017.5202","DOI":"10.1001\/jamaophthalmol.2017.5202"},{"key":"7552_CR43","doi-asserted-by":"publisher","unstructured":"Kim JS, Kim MK, Lee JY, Han BG, Choi SO, Yang JW. The effects of proteinuria on urinary cystatin-C and glomerular filtration rate calculated by serum cystatin-C. Ren Fail. 2012;34:676\u201384.https:\/\/doi.org\/10.3109\/0886022X.2012.672154","DOI":"10.3109\/0886022X.2012.672154"},{"key":"7552_CR44","doi-asserted-by":"publisher","unstructured":"Tkaczyk M, Nowicki M, Lukamowicz J. Increased cystatin C concentration in urine of nephrotic children. Pediatr Nephrol. 2004;19:1278\u201380. https:\/\/doi.org\/10.1007\/s00467-004-1566-1","DOI":"10.1007\/s00467-004-1566-1"}],"container-title":["Journal of Translational Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12967-025-07552-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-025-07552-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-025-07552-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,9]],"date-time":"2026-02-09T13:49:46Z","timestamp":1770644986000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12967-025-07552-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,12]]},"references-count":44,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["7552"],"URL":"https:\/\/doi.org\/10.1186\/s12967-025-07552-6","relation":{},"ISSN":["1479-5876"],"issn-type":[{"value":"1479-5876","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,12]]},"assertion":[{"value":"12 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 December 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 January 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study protocol was approved by the Ethics Committee of Beijing Tongren Hospital, Capital Medical University (TRECKY2020-111), adhering to the Declaration of Helsinki, with written informed consent obtained from all participants.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Authors\u2019 information"}},{"value":"Not applicable.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Footnotes"}},{"value":"The authors declare no competing interests.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"161"}}